Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 3
2008 1
2009 2
2010 3
2011 2
2012 1
2013 3
2014 3
2015 8
2016 9
2017 12
2018 14
2019 19
2020 22
2021 29
2022 31
2023 28
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
Safety of Janus kinase inhibitors compared to biological DMARDs in patients with rheumatoid arthritis and renal impairment: the ANSWER cohort study.
Nakayama Y, Onishi A, Yamamoto W, Yoshikawa A, Shiba H, Yoshida N, Son Y, Shirasugi I, Maeda T, Katsushima M, Hashimoto M, Etani Y, Itami T, Nozaki Y, Onizawa H, Fujii T, Murakami K, Murata K, Tanaka M, Matsuda S, Morinobu A. Nakayama Y, et al. Among authors: hashimoto m. Clin Exp Med. 2024 May 10;24(1):97. doi: 10.1007/s10238-024-01360-w. Clin Exp Med. 2024. PMID: 38727756 Free PMC article.
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study.
Shiomi M, Watanabe R, Matsuda S, Kotani T, Okazaki A, Masuda Y, Yoshida T, Shoji M, Tsuge R, Kadoba K, Hiwa R, Yamamoto W, Takeda A, Itoh Y, Hashimoto M. Shiomi M, et al. Among authors: hashimoto m. Mod Rheumatol. 2024 May 10:roae044. doi: 10.1093/mr/roae044. Online ahead of print. Mod Rheumatol. 2024. PMID: 38727536
Predictive factors and treatment outcomes associated with difficult-to-treat rheumatoid arthritis conditions: the ANSWER cohort study.
Watanabe R, Ebina K, Gon T, Okano T, Murata K, Murakami K, Maeda Y, Jinno S, Shirasugi I, Son Y, Amuro H, Katayama M, Hara R, Hata K, Yoshikawa A, Yamamoto W, Tachibana S, Hayashi S, Etani Y, Katsushima M, Fukumoto K, Yamada S, Hashimoto M. Watanabe R, et al. Among authors: hashimoto m. Rheumatology (Oxford). 2024 May 9:keae265. doi: 10.1093/rheumatology/keae265. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38724245
Energy landscape analysis and time-series clustering analysis of patient state multistability related to rheumatoid arthritis drug treatment: The KURAMA cohort study.
Yamamoto K, Sakaguchi M, Onishi A, Yokoyama S, Matsui Y, Yamamoto W, Onizawa H, Fujii T, Murata K, Tanaka M, Hashimoto M, Matsuda S, Morinobu A. Yamamoto K, et al. Among authors: hashimoto m. PLoS One. 2024 May 6;19(5):e0302308. doi: 10.1371/journal.pone.0302308. eCollection 2024. PLoS One. 2024. PMID: 38709812 Free PMC article.
A preliminary survey of rheumatologists on the management of late-onset rheumatoid arthritis in Japan.
Takanashi S, Kaneko Y, Kawahito Y, Kida T, Sugihara T, Kojima T, Harada R, Ishitoku M, Hirata S, Hashimoto M, Hidaka T, Abe A, Ishikawa H, Ito H, Kishimoto M, Matsui K, Matsui T, Matsushita I, Onishi A, Morinobu A, Nishida K, Asai S, Tanaka E, Harigai M, Kojima M. Takanashi S, et al. Among authors: hashimoto m. Intern Med. 2024 May 2. doi: 10.2169/internalmedicine.3288-23. Online ahead of print. Intern Med. 2024. PMID: 38692915 Free article.
Risk factors for serious infections and infection-related mortality in patients with microscopic polyangiitis: Multicentre REVEAL cohort study.
Manabe A, Kadoba K, Hiwa R, Kotani T, Shoji M, Shirakashi M, Tsuji H, Kitagori K, Akizuki S, Nakashima R, Yoshifuji H, Yamamoto W, Okazaki A, Matsuda S, Gon T, Watanabe R, Hashimoto M, Morinobu A. Manabe A, et al. Among authors: hashimoto m. Mod Rheumatol. 2024 Mar 29:roae024. doi: 10.1093/mr/roae024. Online ahead of print. Mod Rheumatol. 2024. PMID: 38564330
Consensus statement on the management of late-onset rheumatoid arthritis.
Kojima M, Sugihara T, Kawahito Y, Kojima T, Kaneko Y, Ishikawa H, Abe A, Matsui K, Hirata S, Kishimoto M, Tanaka E, Morinobu A, Hashimoto M, Matsushita I, Hidaka T, Matsui T, Nishida K, Asai S, Ito H, Harada R, Harigai M. Kojima M, et al. Among authors: hashimoto m. Mod Rheumatol. 2024 Feb 28:roae011. doi: 10.1093/mr/roae011. Online ahead of print. Mod Rheumatol. 2024. PMID: 38511322
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort study.
Shirasugi I, Onishi A, Nishimura K, Yamamoto W, Murakami K, Onizawa H, Maeda Y, Ebina K, Son Y, Amuro H, Katayama M, Hara R, Nagai K, Hiramatsu Y, Hashimoto M, Okano T, Maeda T, Hayashi S, Sendo S, Jinno S, Yamamoto Y, Yamada H, Ueda Y, Saegusa J. Shirasugi I, et al. Among authors: hashimoto m. Int J Rheum Dis. 2024 Mar;27(3):e15097. doi: 10.1111/1756-185X.15097. Int J Rheum Dis. 2024. PMID: 38439176
182 results